The Trump administration has made significant cuts to HIV and AIDS research, including laying off staff from the US Office of Infectious Disease and HIV/AIDS Policy and cancelling over 230 research grants. This move has left researchers and experts concerned that the progress made towards ending the HIV epidemic in the US will be reversed, potentially leading to a resurgence of the disease.
Forecast for 6 months: The Trump administration’s cuts to HIV research will lead to a decline in new HIV diagnoses in the US, as fewer resources are available to support prevention and treatment efforts.
Forecast for 1 year: The cancellation of research grants will result in a significant delay in the development of new HIV treatments and prevention methods, potentially leading to a rise in HIV-related deaths and new infections.
Forecast for 5 years: The Trump administration’s focus on chronic disease over infectious disease will lead to a significant decrease in funding for HIV research, causing a decline in the number of people living with HIV who receive treatment and care.
Forecast for 10 years: The US will see a resurgence of the HIV epidemic, with a significant increase in new HIV diagnoses and related deaths, as the progress made towards ending the epidemic is reversed due to the lack of funding and research.
